Geode Capital Management, LLC Mi Nk Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Mi Nk Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 96,113 shares of INKT stock, worth $939,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,113
Previous 97,981
1.91%
Holding current value
$939,024
Previous $73,000
12.33%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding INKT
# of Institutions
24Shares Held
810KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA234KShares$2.29 Million0.0% of portfolio
-
Longbow Finance Sa Lutry, V8167KShares$1.63 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny102KShares$993,6770.0% of portfolio
-
Black Rock Inc. New York, NY87.2KShares$851,9040.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL50.7KShares$495,1040.0% of portfolio
About MiNK Therapeutics, Inc.
- Ticker INKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,775,100
- Market Cap $330M
- Description
- MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...